{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:13Z","timestamp":1740126433879,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:p>We read with interest the article recently published by Brown et al. reporting the results of a national cross-sectional study between 2016 and 2018, enrolling 60 000 patients with hidradenitis suppurativa (HS), identifying new correlations between HS and other dermatological conditions, and we wish to report our comment.<\/jats:p>","DOI":"10.1093\/ced\/llad156","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T18:56:21Z","timestamp":1682448981000},"page":"938-939","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u2018Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study\u2019"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-050X","authenticated-orcid":false,"given":"Fabrizio","family":"Martora","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-7391","authenticated-orcid":false,"given":"Angelo","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-637X","authenticated-orcid":false,"given":"Teresa","family":"Battista","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-2046","authenticated-orcid":false,"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"2023101015423249300_llad156-B1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ced\/llad034","article-title":"Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study","volume":"48","author":"Brown","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"2023101015423249300_llad156-B2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clindermatol.2016.10.019","article-title":"Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: an overlooked facet of the immunocompromised district","volume":"35","author":"Fabbrocini","year":"2017","journal-title":"Clin Dermatol"},{"key":"2023101015423249300_llad156-B3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00403-020-02040-x","article-title":"Hidradenitis suppurativa and pemphigus: a cross-sectional study","volume":"312","author":"Kridin","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"2023101015423249300_llad156-B4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000521712","article-title":"A case of pemphigus vulgaris and hidradenitis suppurativa: may systemic steroids be considered in the standard management of hidradenitis suppurativa?","volume":"8","author":"Martora","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"2023101015423249300_llad156-B5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/biomedicines10020455","article-title":"Paradoxical hidradenitis suppurativa during biologic therapy, an emerging challenge: a systematic review","volume":"10","author":"Ruggiero","year":"2022","journal-title":"Biomedicines"},{"key":"2023101015423249300_llad156-B6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/CCID.S391356","article-title":"Adalimumab, ustekinumab, and secukinumab in the management of hidradenitis suppurativa: a review of the real-life experience","volume":"16","author":"Martora","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2023101015423249300_llad156-B7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CCID.S364640","article-title":"Guselkumab, risankizumab, and tildrakizumab in the management of psoriasis: a review of the real-world evidence","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2023101015423249300_llad156-B8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13555-020-00354-2","article-title":"Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice","volume":"10","author":"Tzellos","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2023101015423249300_llad156-B9","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/ced.15306","article-title":"Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: \u2018Evaluating the safety and efficacy of COVID-19 vaccination in patients with\u00a0hidradenitis suppurativa\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2023101015423249300_llad156-B10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/ced.15291","article-title":"Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on \u2018Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad156\/50478666\/llad156.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/938\/51990399\/llad156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/938\/51990399\/llad156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:43:57Z","timestamp":1696952637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/8\/938\/7142637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4,25]]},"published-print":{"date-parts":[[2023,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad156","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,4,25]]}}}